A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Hepatitis B, Chronic
Interventions
DRUG

TQA3038 injection/placebo

TQA3038 is a Anti-Hepatitis B virus (HBV) drugs.

DRUG

Nucleotide drugs Control group

Nucleotide drugs are nucleoside reverse transcriptase inhibitors.

Trial Locations (22)

110006

The sixth people's hospital at of Shenyang, Shenyang

110136

Shengjing Hospital Affiliated to China Medical University, Shenyang

130061

The first hospital of Jilin University, Changchun

130062

Hepatobiliary Hospital of Jilin, Changchun

150000

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

200000

Shanghai Tongren Hospital, Shanghai

233000

The First Affiliated Hospital of Bengbu Medical College, Bengbu

250102

Shandong Public Health Clinical Center, Jinan

300000

People's Hospital of Tianjin (City), Tianjin

330000

The First Affiliated Hospital of Nanchang University, Nanchang

350025

Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou

400038

The Southwest Hospital of AMU, Chongqing

400080

The Second Affilated Hospital of Chongqing medical university, Chongqing

410000

Xiangya Third Hospital of Central of Central Suoth University, Changsha

430030

Tongji Hospital of Tongji medical college of HUST, Wuhan

442000

Shiyan City Taihe Hospital, Shiyan

510630

The Third Affiliated Hospital of Sun Yat sen University, Guangzhou

530021

The First Affiliated Hospital of GUANGXI Medical University, Nanning

550002

Guizhou Provincial People's Hospital, Guiyang

610041

West China Hospital of Sichuan University, Chengdu

730030

Gansu province people hospital, Lanzhou

830054

The First Affiliated Hospital of Xinjiang Medical University, Ürümqi

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY